QSimulate

QSimulate is a quantum simulation software company founded in 2019 by theoretical chemists Toru Shiozaki and Garnet Chan. Based in Boston, Massachusetts, the company focuses on using quantum mechanics to enhance drug discovery and materials science research. With a team of fewer than 25 employees, QSimulate has successfully generated revenue and completed seed financing to support its growth.

The company offers a range of quantum-powered products, including Quelo, a lead optimization platform that significantly speeds up drug discovery simulations; QuValent, specialized software for designing covalent binders; and QuantumFP, a tool for generating data to train AI models. QSimulate's unique approach allows it to efficiently handle complex molecular simulations, setting it apart from competitors in the field. The company has formed collaborations with notable organizations, including Mitsui & Co., Japan Tobacco's drug discovery division, and Google, and it has a presence in the Japanese market through QSimulate Japan.